CC

Chandrika Chintan Bhatt

Active Director Director DIN 11064867
DIN 11064867 First appointment Jan 2019 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Jan 2019
Shareholding value •••• Premium profile

About Chandrika Chintan Bhatt

Data last updated:

Chandrika Chintan Bhatt has 7 years in corporate governance. Holds Director and Company Secretary roles. Currently with 2 companies, including Claroid Pharmaceuticals Limited and Alinea Healthcare Private Limited. Formerly with 3 companies, such as Parker Plant India Private Limited and Cipsa Tec India Private Limited. Engaged in General Business, Healthcare and more. The 2 current companies with reported revenue have a combined latest revenue of ₹121 Cr; the largest is Claroid Pharmaceuticals Limited at ₹98.31 Cr (FY 2025).

DIN 11064867
Primary Designation Director
First Appointment 01 Jan 2019
Oldest Company Age 30 yrs
Largest company Claroid Pharmaceuticals Limited · ₹98.31 Cr (FY 2025)
Combined revenue ₹121 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Claroid Pharmaceuticals Limited U24304GJ2018PLC103796
Director28 Apr 20252018₹98.31 Cr (FY 2025)Active
Alinea Healthcare Private Limited U85190MH1996PTC100107
Company Secretary14 May 20251996₹22.87 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parker Plant India Private Limited U29309GJ2021PTC122504
Company Secretary23 Oct 20242021₹55.48 Cr (FY 2025)Active
Cipsa Tec India Private Limited U30007KA2005PTC037765
Company Secretary01 Aug 20192005₹97.92 Cr (FY 2025)Active
Kapil Raj Finance Limited L65929DL1985PLC022788
Company Secretary01 Jan 20191985₹14.7 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Claroid Pharmaceuticals Limited
Alinea Healthcare Private Limited
Parker Plant India Private Limited
Cipsa Tec India Private Limited
Premium access

Shareholding and investment profile for Chandrika Chintan Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrika Chintan Bhatt

Chandrika Chintan Bhatt has 7 years in corporate governance. Holds Director and Company Secretary roles. Currently with 2 companies, including Claroid Pharmaceuticals Limited and Alinea Healthcare Private Limited. Formerly with 3 companies, such as Parker Plant India Private Limited and Cipsa Tec India Private Limited. Engaged in General Business, Healthcare and more. The 2 current companies with reported revenue have a combined latest revenue of ₹121 Cr; the largest is Claroid Pharmaceuticals Limited at ₹98.31 Cr (FY 2025).

Chandrika Chintan Bhatt is associated with 2 companies as Director and Company Secretary, including Claroid Pharmaceuticals Limited (₹98.31 Cr), Alinea Healthcare Private Limited (₹22.87 Cr).

Chandrika Chintan Bhatt has expertise in General Business, Healthcare and other sectors.

Chandrika Chintan Bhatt has 7 years in corporate governance.

By reported revenue, the largest current company of Chandrika Chintan Bhatt is Claroid Pharmaceuticals Limited, with revenue of ₹98.31 Cr (FY 2025).

The 2 current companies of Chandrika Chintan Bhatt that report revenue have a combined latest revenue of ₹121 Cr.

Chandrika Chintan Bhatt currently holds positions at 2 companies: Claroid Pharmaceuticals Limited (₹98.31 Cr), Alinea Healthcare Private Limited (₹22.87 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available